Bio-Rad Laboratories, Inc. (BIO.B)
NYSE: BIO.B · Real-Time Price · USD
317.05
+6.35 (2.04%)
Dec 5, 2025, 4:00 PM EST - Market closed
Bio-Rad Laboratories Market Cap
Bio-Rad Laboratories has a market cap or net worth of $8.53 billion as of December 5, 2025. Its market cap has decreased by -4.94% in one year.
Market Cap
8.53B
Enterprise Value
8.51B
1-Year Change
-4.94%
Ranking
Category
Stock Price
$317.05
Market Cap Chart
Since December 8, 2020, Bio-Rad Laboratories's market cap has decreased from $16.68B to $8.53B, a decrease of -48.85%. That is a compound annual growth rate of -12.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 8.55B | -7.00% |
| Dec 31, 2024 | 9.20B | -1.07% |
| Dec 29, 2023 | 9.30B | -25.52% |
| Dec 30, 2022 | 12.48B | -44.81% |
| Dec 31, 2021 | 22.62B | 30.09% |
| Dec 31, 2020 | 17.39B | 4.20% |
| Dec 8, 2020 | 16.68B | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |